Estimate the Efficiency of the Association of an Injection of Ketamine and the Venlafaxine in the Severe Major Depressive Disorder for Six Weeks
Brief Summary
The objective of this study is to evaluate the effectiveness of ketamine (infusion of 0.5mg/kg) and venlafaxine compared to the use of venlafaxine alone in the treatment of major depression (MADRS score ≥ 20 ) to six weeks of treatment.
Condition or Disease
- Major Depressive Disorder
Phase
Study Design
| Study type: | Interventional |
|---|---|
| Status: | Completed |
| Study results: | No Results Available |
| Age: | 18 Years and older (Adult, Older Adult) |
| Enrollment: | 25 () |
| Funded by: | Other |
Masking |
|
Clinical Trial Dates
| Start date: | Mar 12, 2020 | |
|---|---|---|
| Primary Completion: | Jan 17, 2020 | |
| Completion Date: | Jan 17, 2020 | |
| Study First Posted: | Mar 19, 2012 | |
| Results First Posted: | Aug 31, 2020 | |
| Last Updated: | Feb 24, 2017 |
Sponsors / Collaborators
Lead Sponsor:
N/A
Responsible Party:
N/A
Eligibility Criteria
| Sex: | All |
|---|---|
| Minimum Age: | 18 |
More Details
| NCT Number: | NCT01557712 |
|---|---|
| Acronym: | KETADEP |
| Other IDs: | 1129 |
| Study URL: | https://ClinicalTrials.gov/show/NCT01557712 |
Last updated: Mar 18, 2021